中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
22期
64-64,66
,共2页
小儿支气管哮喘%硫酸镁%孟鲁司特%临床疗效
小兒支氣管哮喘%硫痠鎂%孟魯司特%臨床療效
소인지기관효천%류산미%맹로사특%림상료효
Children bronchial asthma%Magnesium sulphate%Montelukast%Clinical efficacy
目的：观察小儿支气管哮喘应用硫酸镁与孟鲁司特联合疗法的临床疗效。方法：2011年2月-2014年2月收治支气管哮喘患儿142例，随机平均分为对照组和研究组，每组71例，给予对照组硫酸镁治疗，给予研究组硫酸镁与孟鲁司特联合疗法治疗，记录并分析两组相关情况。结果：研究组干咳、过敏性鼻炎、呼吸困难、心功能衰竭以及面部浮肿等常见临床表现改善情况优于对照组，比较差异均具有统计学意义(P＜0.05)；头晕、呕吐、便秘和皮疹及腹泻不良反应发生率与对照组比较差异无统计学意义(P＞0.05)。结论：小儿支气管哮喘应用硫酸镁与孟鲁司特联合疗法的临床疗效更显著，值得临床推广。
目的：觀察小兒支氣管哮喘應用硫痠鎂與孟魯司特聯閤療法的臨床療效。方法：2011年2月-2014年2月收治支氣管哮喘患兒142例，隨機平均分為對照組和研究組，每組71例，給予對照組硫痠鎂治療，給予研究組硫痠鎂與孟魯司特聯閤療法治療，記錄併分析兩組相關情況。結果：研究組榦咳、過敏性鼻炎、呼吸睏難、心功能衰竭以及麵部浮腫等常見臨床錶現改善情況優于對照組，比較差異均具有統計學意義(P＜0.05)；頭暈、嘔吐、便祕和皮疹及腹瀉不良反應髮生率與對照組比較差異無統計學意義(P＞0.05)。結論：小兒支氣管哮喘應用硫痠鎂與孟魯司特聯閤療法的臨床療效更顯著，值得臨床推廣。
목적：관찰소인지기관효천응용류산미여맹로사특연합요법적림상료효。방법：2011년2월-2014년2월수치지기관효천환인142례，수궤평균분위대조조화연구조，매조71례，급여대조조류산미치료，급여연구조류산미여맹로사특연합요법치료，기록병분석량조상관정황。결과：연구조간해、과민성비염、호흡곤난、심공능쇠갈이급면부부종등상견림상표현개선정황우우대조조，비교차이균구유통계학의의(P＜0.05)；두훈、구토、편비화피진급복사불량반응발생솔여대조조비교차이무통계학의의(P＞0.05)。결론：소인지기관효천응용류산미여맹로사특연합요법적림상료효경현저，치득림상추엄。
Objective:To observe the clinical efficacy of application magnesium sulfate combined with montelukast therapy on children bronchial asthma.Methods:142 children with bronchial asthma were selected from February 2011 to February 2014.They were randomly divided into the control group and the study group with 71 cases in each.The control group received the treatment of magnesium sulfate.The study group were given magnesium sulfate combined with montelukast.We recorded and analyzed the relevant circumstances of two groups.Results:The common clinical manifestations of dry cough,allergic rhinitis,difficulty in breathing,heart failure and puffy face of the study group improved better than that of the control group,and the differences were statistically significant(P<0.05).The incidence of dizziness,vomiting,constipation and diarrhea and rash adverse reaction had no significant difference between two groups (P>0.05).Conclusion:Magnesium sulfate combined with montelukast treated on children bronchial asthma can acheive more significant clinical efficacy,so it is worthy of clinical promotion.
